Dr. Erin L Spillane, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 314 Franklin Ave, Suite 107, Berlin, MD 21811 Phone: 410-641-2222 Fax: 844-715-9464 |
Dr. Anne Patricia Spillane, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 314 Franklin Ave, Suite 107, Berlin, MD 21811 Phone: 410-641-2222 Fax: 844-715-9464 |
Dr. Mary Katherine Mather, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9948 N Main St Ste 1, Berlin, MD 21811 Phone: 443-351-3376 |
Dr. Monte Sean Meltzer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9948 N Main St Ste 1, Berlin, MD 21811 Phone: 443-351-3376 Fax: 443-736-1945 |
News Archive
Elementary and middle school students who are given at least 25 minutes to eat lunch are more likely to choose fruits and consume more of their entrees, milk, and vegetables according to a new study released in the Journal of the Academy of Nutrition and Dietetics.
A revealing study published in Epilepsy & Behavior provides evidence that the perception of epilepsy is not faring well in social media. Kate McNeil and colleagues from Dalhousie University in Canada analyzed data collected from Twitter to provide a snapshot of how epilepsy is portrayed within the twitter community.
BioSante Pharmaceuticals, Inc. today announced it has been added to the broad-market Russell 3000 Index as part of Russell Investments' recent reconstitution of its comprehensive set of U.S. and global equity indexes which occurred after market close on June 25, 2010.
EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, today announced plans to move forward with a Phase 2a clinical trial in the U.S. using its formulation of EGFR-targeted, EDV nanocells packaged with doxorubicin for the treatment of recurrent glioblastoma (GBM), a common and aggressive type of brain tumor.
› Verified 7 days ago